Itraconazole: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
| + | == Background == |
||
* Azole antifungal |
* Azole antifungal |
||
* Indications include {{#ask: [[Is treated by::itraconazole]]}} |
* Indications include {{#ask: [[Is treated by::itraconazole]]}} |
||
| + | == Dosing == |
||
| ⚫ | |||
| + | |||
| + | * Typical dose: 200 mg p.o. twice daily |
||
| + | * May be used once daily for the treatment of some [[dermatophytes]] |
||
| + | |||
| + | == Safety == |
||
| + | |||
| ⚫ | |||
* Should be measured 5 to 7 days after starting or changing the dose, or when interacting medications are changed |
* Should be measured 5 to 7 days after starting or changing the dose, or when interacting medications are changed |
||
* Target in prophylaxis is a trough ot 0.5 mg/L |
* Target in prophylaxis is a trough ot 0.5 mg/L |
||
* Target in treatment is a trough >0.5 mg/L |
* Target in treatment is a trough >0.5 mg/L |
||
| − | == Adverse Drug Reactions == |
+ | === Adverse Drug Reactions === |
* [[Adverse drug reaction::Headache]] |
* [[Adverse drug reaction::Headache]] |
||
* [[Adverse drug reaction::Relative adrenal insufficiency]] |
* [[Adverse drug reaction::Relative adrenal insufficiency]] |
||
Revision as of 12:51, 2 January 2024
Background
- Azole antifungal
- Indications include Alternaria, Blastomyces dermatitidis, Chromoblastomycosis, Coccidioides immitis, Cryptococcus, Entomophthoromycotina, Exophiala, Exserohilum, Fonsecaea, Histoplasma capsulatum, Mycetoma, Paracoccidioides brasiliensis, Sappinia diploidea, Sporothrix schenckii
Dosing
- Typical dose: 200 mg p.o. twice daily
- May be used once daily for the treatment of some dermatophytes
Safety
Therapeutic Drug Monitoring
- Should be measured 5 to 7 days after starting or changing the dose, or when interacting medications are changed
- Target in prophylaxis is a trough ot 0.5 mg/L
- Target in treatment is a trough >0.5 mg/L
